Glycosyltransferase glycosylating flavokermesic acid and/or or kermesic acid

US10100290B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10100290-B2
Application numberUS-201415105673-A
CountryUS
Kind codeB2
Filing dateDec 18, 2014
Priority dateDec 18, 2013
Publication dateOct 16, 2018
Grant dateOct 16, 2018

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

An isolated glycosyltransferase (GT) polypeptide capable of: (I): conjugating glucose to flavokermesic acid (FK); and/or (II): conjugating glucose to kermesic acid (KA) and use of this GT to e.g. make Carminic acid.

First claim

Opening claim text (preview).

The invention claimed is: 1. A recombinant expression vector comprising a nucleic acid construct comprising an isolated polynucleotide comprising a nucleotide sequence which encodes an isolated glycosyltransferase polypeptide capable of: (I): conjugating nucleotide activated glucose to flavokermesic acid (FK); and/or (II): conjugating nucleotide activated glucose to kermesic acid (KA); and wherein the glycosyltransferase polypeptide is at least one polypeptide selected from the group consisting of: (a) a polypeptide comprising an amino acid sequence which has at least 95% identity with amino acids 1 to 515 of SEQ ID NO:2; and (b) a polypeptide comprising an amino acid sequence which has at least 95% identity with amino acids 20 to 468 of SEQ ID NO:2; and wherein said polynucleotide is operably linked to one or more control sequences that direct the production of the polypeptide in an expression host. 2. A recombinant host cell comprising the recombinant expression vector of claim 1 . 3. The recombinant host cell of claim 2 , wherein the recombinant host cell is a cell selected from the group consisting of a filamentous fungal cell and a microorganism cell, and wherein if the microorganism cell is a yeast cell, the yeast cell is selected from the group consisting of Saccharomyces spp, and Pichia spp. 4. The recombinant host cell of claim 3 , wherein the recombinant host cell is Saccharomyces cerevisiae.

Assignees

Inventors

Classifications

  • Glycosyltransferases (2.4) · CPC title

  • for yeasts · CPC title

  • Hexosyltransferases (2.4.1) · CPC title

  • C12N9/1048Primary

    Glycosyltransferases (2.4) · CPC title

  • Bacteria; Culture media therefor · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10100290B2 cover?
An isolated glycosyltransferase (GT) polypeptide capable of: (I): conjugating glucose to flavokermesic acid (FK); and/or (II): conjugating glucose to kermesic acid (KA) and use of this GT to e.g. make Carminic acid.
Who is the assignee on this patent?
Univ Copenhagen, Univ Danmarks Tekniske
What technology area does this patent fall under?
Primary CPC classification C12N9/1048. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Oct 16 2018 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 2 related publications on this page (citations in our corpus or others sharing the same primary CPC).